PTAB with the DETOUR System offers a novel approach to treating complex PAD, enabling physicians to bypass lesions in the superficial femoral artery, by using stents routed through the femoral ...

TCT 899: Utilizing the Superficial Femoral Artery for Primary Vascular Access in Transcatheter Aortic Valve Implantation ...

Far from aggravating the signs of venous stasis, a common femoral or iliac division results in lessened distention of the superficial veins and an improved color of the foot.

The position of the lateral circumflex femoral vein posterior to the deep femoral artery played a role in this distinctive, lengthy, and superficial presentation of the deep femoral artery. This ...

The superficial femoral artery from the common femoral artery to the origin of Hunter’s canal was normal. There was no leakage of the superficial femoral artery after injection of contrast medium ...

Cordis, a global leader in the development and manufacturing of interventional cardiovascular and endovascular technology, today announces positive 24-month results from the SELUTION SFA Japan Trial.

One-year results of the DETOUR2 trial published in the Journal of Vascular Surgery demonstrate outstanding results for Endologix LLC’s percutaneous transmural arterial bypass system for treatment of ...

Background— Endoluminal treatment of superficial femoral artery lesions is a matter of controversy. The present study was designed to investigate the impact of nitinol stenting of superficial femoral ...

BioWorld Content on 'superficial femoral artery'Pq Bypass Inc. received breakthrough device designation from the FDA for its Detour system, the first to permit fully percutaneous femoropopliteal ...